Results 1 to 10 of about 635,464 (240)

Overview of Therapeutic Drug Monitoring [PDF]

open access: yesThe Korean journal of internal medicine, 2009
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic
Min Ho Lee, Ju Seop Kang
openaire   +5 more sources

Therapeutic Drug Monitoring [PDF]

open access: yesJournal of the International Association of Physicians in AIDS Care, 2002
Traditionally, therapeutic drug monitoring has been used for the management of epilepsy, cardiac arrhythmias, asthma and depression. This review provides an update, particularly for the newer clinical applications, and how therapeutic drug monitoring (including use of analytical and interpretation tools) can improve clinical outcomes.Improved drug ...
David, Back, Saye, Khoo, Sara, Gibbons
openaire   +4 more sources

Therapeutic drug monitoring in drug overdose [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1999
The treatment of poisoned patients is still largely defined by history, clinical assessment and interpretation of ancillary investigations. Measurement of drug concentrations is clinically important for relatively few compounds. Most measurements form an adjunct to and should not be considered a substitute for clinical assessment.
Ian M Whyte, Andrew H. Dawson
openaire   +7 more sources

Therapeutic drug monitoring: antiarrhythmic drugs [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1998
Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast‐inward sodium channel on myocardium. These agents have a very significant toxicity, and while
T. J. Campbell, K. M. Williams
openaire   +6 more sources

On-Site Therapeutic Drug Monitoring [PDF]

open access: yesTrends in Biotechnology, 2020
Recent technological advances have stimulated efforts to bring personalized medicine into practice. Yet, traditional application fields like therapeutic drug monitoring (TDM) have remained rather under-appreciated. Owing to clear dose-response relationships, TDM could improve patient outcomes and reduce healthcare costs.
H. Ceren Ates   +7 more
openaire   +4 more sources

Therapeutic Drug Monitoring

open access: yesYAKUGAKU ZASSHI, 2007
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Tadaaki, Ito   +5 more
openaire   +3 more sources

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics. [PDF]

open access: yes, 2012
The immunosuppressive drugs used to prevent the rejection of transplanted organs have a narrow therapeutic index. Under treatment results in episodes of rejection leading to either damage or loss of the organ. Over immunosuppression increases the risk of
Abboudi, H, Macphee, IA
core   +2 more sources

Therapeutic drug monitoring – antiepileptic drugs [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1998
Aims  To provide a brief critical review of the basis and contemporary practice of monitoring the concentrations of antiepileptic drugs in biological fluids. Methods  The review is based on literature data and observations from clinical practice.
openaire   +9 more sources

Therapeutic Drug Monitoring and Methods of Quantitation for Carbamazepine [PDF]

open access: yes, 2017
Carbamazepine is an early anticonvulsant still used today in the treatment of several forms of epilepsy. An active metabolite in the human body contributes to its pharmacological effect.
Ana Vlasceanu   +7 more
core   +4 more sources

Bayesian data assimilation to support informed decision-making in individualized chemotherapy [PDF]

open access: yes, 2020
An essential component of therapeutic drug/biomarker monitoring (TDM) is to combine patient data with prior knowledge for model-based predictions of therapy outcomes.
de Wiljes, Jana   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy